MedTrace Logo

Application of a Mindfulness and Self-Compassion Program in Patients With Schizophrenia. Randomized Controlled Trial.

NCT04144075 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2019-11-04

No results posted yet for this study

Summary

This is a randomized clinical trial to check whether the quality of life of patients with schizophrenia improves after participation in the mindfulness and self-compassion (MSC) programme.

Conditions

Interventions

BEHAVIORAL

Mindful Self-Compassion Program

It is a protocolized training program in mindfulness and self-compassion skills. It has a duration of 8 weekly group sessions of about two hours and 45 minutes and a silent retreat of 4 hours.

BEHAVIORAL

Cognitive Behaviour Therapy Group

It is a control intervention designed for the development of a control group suitable for comparison with experimental groups.

OTHER

Treatment as usual

It is variable according to the clinical and personal characteristics of the patient, the most common components will be described.

Sponsors & Collaborators

  • Gutiérrez-Hernández, ME

    lead OTHER

Principal Investigators

  • Alicia Díaz Megolla · Universidad de Las Palmas de Gran Canaria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-08-15
Completion
2021-02-15

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04144075 on ClinicalTrials.gov